{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T10:33:56Z","timestamp":1794134036212,"version":"4.8.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Top Institute Food and Nutrition","award":["grant CH-003"],"award-info":[{"award-number":["grant CH-003"]}],"id":[{"id":"https:\/\/ror.org\/04wpjg525","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methylmalonic acid (MMA) is best known for its use as a functional marker of vitamin B12 deficiency. However, MMA concentrations not only depend on adequate vitamin B12 status, but also relate to renal function and endogenous production of propionic acid. Hence, we aimed to investigate to what extent variation in MMA levels is explained by vitamin B12 and eGFR and whether MMA levels are associated with mortality if vitamin B12 and eGFR are taken into account.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1533 individuals (aged 60\u201375\u2009years, 50% male) were included from the Lifelines Cohort and Biobank Study. Individuals were included between 2006 and 2013, and the total follow-up time was 8.5\u2009years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median [IQR] age of the study population was 65 [62\u201369] years, 50% was male. At baseline, median MMA concentration was 170 [138\u2013216] nmol\/L, vitamin B12 290 [224\u2013362] pmol\/L, and eGFR 84 [74\u201391] mL\/min\/1.73\u2009m2. Log\n                      <jats:sub>2<\/jats:sub>\n                      vitamin B12, log\n                      <jats:sub>2<\/jats:sub>\n                      eGFR, age, and sex were significantly associated with log\n                      <jats:sub>2<\/jats:sub>\n                      MMA in multivariable linear regression analyses (model\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.22). After a total follow-up time of 8.5\u2009years, 72 individuals had died. Log\n                      <jats:sub>2<\/jats:sub>\n                      MMA levels were significantly associated with mortality (hazard ratio [HR] 1.67 [95% CI 1.25\u20132.22],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Moreover, we found a significant interaction between MMA and eGFR with respect to mortality (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>interaction<\/jats:sub>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Only 22% of variation in MMA levels was explained by vitamin B12, eGFR, age, and sex, indicating that a large part of variation in MMA levels is attributable to other factors (e.g., catabolism, dietary components, or gut microbial production). Higher MMA levels are associated with an increased risk for mortality, independent of vitamin B12, eGFR, and sex. This association was more pronounced in individuals with impaired renal function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-020-01853-x","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T21:05:07Z","timestamp":1607547907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Methylmalonic acid, vitamin B12, renal function, and risk of all-cause mortality in the general population: results from the prospective Lifelines-MINUTHE study"],"prefix":"10.1186","volume":"18","author":[{"given":"Ineke J.","family":"Riphagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidor","family":"Minovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion","family":"Groothof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred L.","family":"Eggersdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny E.","family":"Kootstra-Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerjan","family":"Navis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits A. J.","family":"Muskiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido P.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Rebecca","family":"Heiner-Fokkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan J. L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"issue":"8 Pt 2","key":"1853_CR1","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/clinchem\/46.8.1277","volume":"46","author":"GG Klee","year":"2000","unstructured":"Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B (12) and folate. Clin Chem. 2000;46(8 Pt 2):1277\u201383.","journal-title":"Clin Chem"},{"issue":"12","key":"1853_CR2","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1373\/clinchem.2009.128678","volume":"55","author":"A Vogiatzoglou","year":"2009","unstructured":"Vogiatzoglou A, Oulhaj A, Smith AD, Nurk E, Drevon CA, Ueland PM, Vollset SE, Tell GS, Refsum H. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status. Clin Chem. 2009;55(12):2198\u2013206.","journal-title":"Clin Chem"},{"issue":"8","key":"1853_CR3","first-page":"739","volume":"39","author":"W Herrmann","year":"2001","unstructured":"Herrmann W, Schorr H, Geisel J, Riegel W. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease. Clin Chem Lab Med. 2001;39(8):739\u201346.","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"1853_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/0004563218778300","volume":"55","author":"SL van Loon","year":"2018","unstructured":"van Loon SL, Wilbik AM, Kaymak U, van den Heuvel ER, Scharnhorst V, Boer AK. Improved testing for vitamin B12 deficiency: correcting MMA for eGFR reduces the number of patients classified as vitamin B12 deficient. Ann Clin Biochem. 2018;55(6):685\u201392.","journal-title":"Ann Clin Biochem"},{"issue":"11","key":"1853_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.bbalip.2010.07.007","volume":"1801","author":"SH Al-Lahham","year":"2010","unstructured":"Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta. 2010;1801(11):1175\u201383.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1853_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1753-4887.2011.00388.x","volume":"69","author":"E Hosseini","year":"2011","unstructured":"Hosseini E, Grootaert C, Verstraete W, Van de Wiele T. Propionate as a health-promoting microbial metabolite in the human gut. Nutr Rev. 2011;69(5):245\u201358.","journal-title":"Nutr Rev"},{"issue":"6\u20137","key":"1853_CR7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/0006-2952(91)90209-N","volume":"41","author":"S Krahenbuhl","year":"1991","unstructured":"Krahenbuhl S, Brass EP. Inhibition of hepatic propionyl-CoA synthetase activity by organic acids. Reversal of propionate inhibition of pyruvate metabolism. Biochem Pharmacol. 1991;41(6\u20137):1015\u201323.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"1853_CR8","doi-asserted-by":"publisher","first-page":"e0137203","DOI":"10.1371\/journal.pone.0137203","volume":"10","author":"B Klijs","year":"2015","unstructured":"Klijs B, Scholtens S, Mandemakers JJ, Snieder H, Stolk RP, Smidt N. Representativeness of the LifeLines Cohort Study. PLoS One. 2015;10(9):e0137203.","journal-title":"PLoS One"},{"issue":"4","key":"1853_CR9","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/ije\/dyu229","volume":"44","author":"S Scholtens","year":"2015","unstructured":"Scholtens S, Smidt N, Swertz MA, Bakker SJ, Dotinga A, Vonk JM, van Dijk F, van Zon SK, Wijmenga C, Wolffenbuttel BH, Stolk RP. Cohort profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2015;44(4):1172\u201380.","journal-title":"Int J Epidemiol"},{"key":"1853_CR10","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF,3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): a new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150(9):604\u2013612.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"issue":"Suppl 1","key":"1853_CR11","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1007\/PL00014275","volume":"156","author":"JV Leonard","year":"1997","unstructured":"Leonard JV. Stable isotope studies in propionic and methylmalonic acidaemia. Eur J Pediatr. 1997;156(Suppl 1):S67\u20139.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"1853_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29\u201341.","journal-title":"Environ Microbiol"},{"key":"1853_CR13","doi-asserted-by":"crossref","unstructured":"Sba\u00c3\u00af D, Narcy C, Thompson GN, Mariotti A, Poggi F, Saudubray JM, Bresson JL: Contribution of odd-chain fatty acid oxidation to propionate production in disorders of propionate metabolism. Am J Clin Nutr 1994, 59(6):1332\u20131337.","DOI":"10.1093\/ajcn\/59.6.1332"},{"issue":"11","key":"1853_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/0026-0495(90)90084-P","volume":"39","author":"GN Thompson","year":"1990","unstructured":"Thompson GN, Walter JH, Bresson JL, Ford GC, Lyonnet SL, Chalmers RA, Saudubray JM, Leonard JV, Halliday D. Sources of propionate in inborn errors of propionate metabolism. Metabolism. 1990;39(11):1133\u20137.","journal-title":"Metabolism"},{"issue":"9","key":"1853_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41581-019-0172-1","volume":"15","author":"B Meijers","year":"2019","unstructured":"Meijers B, Evenepoel P, Anders HJ. Intestinal microbiome and fitness in kidney disease. Nat Rev Nephrol. 2019;15(9):531\u201345.","journal-title":"Nat Rev Nephrol"},{"key":"1853_CR16","doi-asserted-by":"publisher","unstructured":"Nie C, He T, Zhang W, Zhang G, Ma X: Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci 2018, 19(4):https:\/\/doi.org\/10.3390\/ijms19040954.","DOI":"10.3390\/ijms19040954"},{"issue":"4","key":"1853_CR17","first-page":"495","volume":"33","author":"C Gracia-Iguacel","year":"2013","unstructured":"Gracia-Iguacel C, Gonzalez-Parra E, Perez-Gomez MV, Mahillo I, Egido J, Ortiz A, Carrero JJ. Prevalence of protein-energy wasting syndrome and its association with mortality in haemodialysis patients in a Centre in Spain. Nefrologia. 2013;33(4):495\u2013505.","journal-title":"Nefrologia"},{"issue":"9","key":"1853_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrneph.2014.112","volume":"10","author":"XH Wang","year":"2014","unstructured":"Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014;10(9):504\u201316.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1853_CR19","doi-asserted-by":"publisher","first-page":"e0147843","DOI":"10.1371\/journal.pone.0147843","volume":"11","author":"P Vashi","year":"2016","unstructured":"Vashi P, Edwin P, Popiel B, Lammersfeld C, Gupta D. Methylmalonic acid and homocysteine as indicators of vitamin B-12 deficiency in cancer. PLoS One. 2016;11(1):e0147843.","journal-title":"PLoS One"},{"issue":"8","key":"1853_CR20","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1007\/s00520-016-3175-5","volume":"24","author":"LR Solomon","year":"2016","unstructured":"Solomon LR. Functional vitamin B12 deficiency in advanced malignancy: implications for the management of neuropathy and neuropathic pain. Support Care Cancer. 2016;24(8):3489\u201394.","journal-title":"Support Care Cancer"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-020-01853-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T21:05:57Z","timestamp":1607547957000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01853-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01853-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"26 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided written consent. The Lifelines Cohort Study was conducted according to the principles of the Declaration of Helsinki and approved by the Medical ethical committee of the University Medical Center Groningen, the Netherlands (METc approval number 2007\/152).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}